Tekla Capital Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-29,024
Closed -$3.52M 176
2022
Q3
$3.52M Sell
29,024
-84,206
-74% -$10.8M 0.14% 95
2022
Q2
$14.5M Hold
113,230
0.57% 49
2022
Q1
$15.5M Hold
113,230
0.54% 49
2021
Q4
$16M Sell
113,230
-19,600
-15% -$2.6M 0.51% 49
2021
Q3
$16.9M Sell
132,830
-56,100
-30% -$7.41M 0.54% 51
2021
Q2
$23.8M Buy
188,930
+178,875
+1,779% +$21.9M 0.77% 34
2021
Q1
$1.17M Hold
10,055
0.04% 174
2020
Q4
$1.14M Hold
10,055
0.04% 174
2020
Q3
$1.06M Hold
10,055
0.04% 177
2020
Q2
$1.01M Hold
10,055
0.04% 191
2020
Q1
$891K Sell
10,055
-43,718
-81% -$4.25M 0.04% 183
2019
Q4
$5.48M Buy
+53,773
New +$5.17M 0.21% 97
2017
Q2
Sell
-140,600
Closed -$10.5M 149
2017
Q1
$10.5M Buy
+140,600
New +$10.2M 0.41% 52

Other funds holding XLV

Tekla Capital Management's XLV Position: Q4 2022 in Review

Tekla Capital Management sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2022, closing a stake of 29,024 shares — an estimated $3.52M sold.

Tekla Capital Management first reported a position in XLV in Q1 2017 and held it in 13 quarters. The position peaked at $23.8M in Q2 2021. 1,607 funds tracked by Wall St. Rank hold XLV as of Q4 2022.

  • Tekla Capital Management reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2022 after selling out during the quarter.
  • Tekla Capital Management sold 29,024 State Street Health Care Select Sector SPDR ETF shares in Q4 2022, an estimated $3.52M.
  • Tekla Capital Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2017 and held it in 13 quarters.
  • Tekla Capital Management's State Street Health Care Select Sector SPDR ETF position peaked at $23.8M in Q2 2021.
  • 1,607 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2022.

Based on Tekla Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.